Follow this preprint
Performance of LFSPRO TP53 germline carrier risk predictions compared to standard genetic counseling practice on prospectively collected probands
Jessica L. Corredor, Elissa B. Dodd-Eaton, Jacynda Woodman-Ross, Ashley Woodson, Nam H. Nguyen, Gang Peng, Sierra Green, Angelica M. Gutierrez, Banu K. Arun, View ORCID ProfileWenyi Wang
doi: https://doi.org/10.1101/2024.07.09.24310095
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Jessica L. Corredor
1The University of Texas MD Anderson Cancer Center, Department of Clinical Cancer Genetics, Houston, TX
MS, CGCElissa B. Dodd-Eaton
2The University of Texas MD Anderson Cancer Center, Department of Bioinformatics and Computational Biology, Houston, TX
MPHJacynda Woodman-Ross
1The University of Texas MD Anderson Cancer Center, Department of Clinical Cancer Genetics, Houston, TX
MS, CGCAshley Woodson
1The University of Texas MD Anderson Cancer Center, Department of Clinical Cancer Genetics, Houston, TX
MS, CGCNam H. Nguyen
2The University of Texas MD Anderson Cancer Center, Department of Bioinformatics and Computational Biology, Houston, TX
3Rice University, Department of Statistics, Houston, TX
PhDGang Peng
4Indiana University School of Medicine, Department of Medical and Molecular Genetics, Indianapolis, IN
PhDSierra Green
1The University of Texas MD Anderson Cancer Center, Department of Clinical Cancer Genetics, Houston, TX
BSAngelica M. Gutierrez
5The University of Texas MD Anderson Cancer Center, Department of Breast Medical Oncology, Houston, TX
MSBanu K. Arun
1The University of Texas MD Anderson Cancer Center, Department of Clinical Cancer Genetics, Houston, TX
5The University of Texas MD Anderson Cancer Center, Department of Breast Medical Oncology, Houston, TX
MDWenyi Wang
2The University of Texas MD Anderson Cancer Center, Department of Bioinformatics and Computational Biology, Houston, TX
PhD![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted July 10, 2024.
Performance of LFSPRO TP53 germline carrier risk predictions compared to standard genetic counseling practice on prospectively collected probands
Jessica L. Corredor, Elissa B. Dodd-Eaton, Jacynda Woodman-Ross, Ashley Woodson, Nam H. Nguyen, Gang Peng, Sierra Green, Angelica M. Gutierrez, Banu K. Arun, Wenyi Wang
medRxiv 2024.07.09.24310095; doi: https://doi.org/10.1101/2024.07.09.24310095
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Subject Area
Subject Areas
- Addiction Medicine (408)
- Allergy and Immunology (721)
- Anesthesia (214)
- Cardiovascular Medicine (3047)
- Dermatology (258)
- Emergency Medicine (456)
- Epidemiology (12965)
- Forensic Medicine (12)
- Gastroenterology (849)
- Genetic and Genomic Medicine (4780)
- Geriatric Medicine (441)
- Health Economics (747)
- Health Informatics (3032)
- Health Policy (1097)
- Hematology (405)
- HIV/AIDS (953)
- Medical Education (450)
- Medical Ethics (119)
- Nephrology (492)
- Neurology (4553)
- Nursing (243)
- Nutrition (673)
- Oncology (2367)
- Ophthalmology (667)
- Orthopedics (264)
- Otolaryngology (332)
- Pain Medicine (297)
- Palliative Medicine (86)
- Pathology (512)
- Pediatrics (1232)
- Primary Care Research (516)
- Public and Global Health (7141)
- Radiology and Imaging (1589)
- Respiratory Medicine (941)
- Rheumatology (456)
- Sports Medicine (396)
- Surgery (506)
- Toxicology (63)
- Transplantation (218)
- Urology (188)